About Jewish Hospital BMT Program
"The Jewish Hospital - Mercy Health Cincinnati Cancer and Cellular Therapy Center is the most advanced adult blood and bone marrow transplant program across Ohio, Indiana and Kentucky. Our Blood Cancer Center nationally recognized and accredited."
Clinical Trials at Jewish Hospital BMT Program
During the past decade, Jewish Hospital BMT Program conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 9 clinical trials were completed, i.e. on
average, 900% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Jewish Hospital BMT Program"
#1 collaborator was "National Cancer Institute (NCI)" with 12 trials as a collaborator, "Blood and Marrow Transplant Clinical Trials Network" with 7 trials as a collaborator, "National Marrow Donor Program" with 6 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 4 trials as a collaborator and "Medical Research Council" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were
collaborators in the rest 5 trials.
Clinical Trials Conditions at Jewish Hospital BMT Program
According to Clinical.Site data, the most researched conditions in "Jewish Hospital BMT Program" are
"Leukemia" (4 trials), "Multiple Myeloma" (3 trials), "Lymphoma" (2 trials), "Acute Lymphocytic Leukemia" (1 trials) and "Acute Myelogenous Leukemia" (1 trials). Many other conditions were trialed in "Jewish Hospital BMT Program" in a lesser frequency.
Clinical Trials Intervention Types at Jewish Hospital BMT Program
Most popular intervention types in "Jewish Hospital BMT Program" are "Drug" (9 trials), "Procedure" (5 trials), "Biological" (3 trials), "Radiation" (3 trials) and "Behavioral" (1 trials). Other intervention types were less common.
The name of intervention was led by "Lenalidomide" (2 trials), "cyclophosphamide" (2 trials), "cytarabine" (2 trials), "sargramostim" (2 trials) and "Allogeneic HCT" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Jewish Hospital BMT Program
The vast majority of trials in "Jewish Hospital BMT Program" are
12 trials for "All" genders.
Clinical Trials Status at Jewish Hospital BMT Program
Currently, there are NaN active trials in "Jewish Hospital BMT Program".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 10 completed trials in Jewish Hospital BMT Program,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Jewish Hospital BMT Program, 0 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 9 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".